These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30204118)

  • 1. EPIDEMIOLOGY OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE IN INTENSIVE CARE UNITS OF MULTIPROFILE HOSPITALS IN TBILISI, GEORGIA.
    Tsereteli M; Sidamonidze K; Tsereteli D; Malania L; Vashakidze E
    Georgian Med News; 2018; (280-281):164-168. PubMed ID: 30204118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.
    Veeraraghavan B; Shankar C; Karunasree S; Kumari S; Ravi R; Ralph R
    Pathog Glob Health; 2017 Jul; 111(5):240-246. PubMed ID: 28670975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
    Gaibani P; Colombo R; Arghittu M; Cariani L; Ambretti S; Bua G; Lombardo D; Landini MP; Torresani E; Sambri V
    New Microbiol; 2014 Jan; 37(1):87-90. PubMed ID: 24531175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
    Büyüktuna SA; Hasbek M; Çelik C; Ünlüsavuran M; Avcı O; Baltacı S; Fırtına Topcu K; Elaldı N
    Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
    Zhang X; Chen D; Xu G; Huang W; Wang X
    PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
    Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
    Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
    Corbellini S; Caccuri F; Gelmi M; De Francesco MA; Fiorentini S; Caruso A; Giagulli C
    New Microbiol; 2014 Apr; 37(2):177-83. PubMed ID: 24858644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
    De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M
    Future Microbiol; 2015; 10(2):283-94. PubMed ID: 25689539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan.
    Saleem AF; Qamar FN; Shahzad H; Qadir M; Zaidi AK
    Int J Infect Dis; 2013 Nov; 17(11):e961-5. PubMed ID: 23759260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
    Us E; Tekeli A; Arikan Akan O; Dolapci I; Sahin F; Karahan ZC
    Mikrobiyol Bul; 2010 Jan; 44(1):1-10. PubMed ID: 20455393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.
    Akturk H; Sutcu M; Somer A; Aydın D; Cihan R; Ozdemir A; Coban A; Ince Z; Citak A; Salman N
    Braz J Infect Dis; 2016; 20(2):134-40. PubMed ID: 26867474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
    Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
    Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.